WINTON GROUP Ltd Sells 164,275 Shares of Pediatrix Medical Group, Inc. $MD

WINTON GROUP Ltd trimmed its position in shares of Pediatrix Medical Group, Inc. (NYSE:MD) by 76.4% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 50,821 shares of the company’s stock after selling 164,275 shares during the period. WINTON GROUP Ltd owned about 0.06% of Pediatrix Medical Group worth $1,087,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Global Retirement Partners LLC raised its stake in shares of Pediatrix Medical Group by 68,250.0% during the fourth quarter. Global Retirement Partners LLC now owns 1,367 shares of the company’s stock valued at $29,000 after acquiring an additional 1,365 shares during the last quarter. Eurizon Capital SGR S.p.A. bought a new position in shares of Pediatrix Medical Group during the fourth quarter valued at about $33,000. Blue Trust Inc. bought a new position in shares of Pediatrix Medical Group during the fourth quarter valued at about $37,000. TD Private Client Wealth LLC bought a new position in shares of Pediatrix Medical Group during the fourth quarter valued at about $39,000. Finally, KBC Group NV bought a new position in shares of Pediatrix Medical Group during the fourth quarter valued at about $65,000. 97.71% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

Several brokerages have recently commented on MD. UBS Group upped their price objective on shares of Pediatrix Medical Group from $22.00 to $25.00 and gave the company a “neutral” rating in a research note on Tuesday, May 12th. Mizuho set a $24.00 price objective on shares of Pediatrix Medical Group in a research note on Friday, May 8th. Truist Financial upped their price objective on shares of Pediatrix Medical Group from $21.00 to $23.00 and gave the company a “hold” rating in a research note on Monday, April 13th. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Pediatrix Medical Group in a research note on Friday, March 27th. Finally, Jefferies Financial Group reaffirmed a “buy” rating and set a $27.00 price objective on shares of Pediatrix Medical Group in a research note on Monday, April 20th. One investment analyst has rated the stock with a Buy rating and five have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus price target of $22.50.

Pediatrix Medical Group Price Performance

Shares of NYSE MD opened at $23.69 on Wednesday. Pediatrix Medical Group, Inc. has a 1 year low of $11.84 and a 1 year high of $24.99. The company has a debt-to-equity ratio of 0.45, a current ratio of 1.33 and a quick ratio of 1.33. The company’s 50-day moving average is $22.24 and its 200 day moving average is $21.69. The stock has a market capitalization of $1.95 billion, a P/E ratio of 11.50 and a beta of 0.69.

Pediatrix Medical Group (NYSE:MD) last announced its quarterly earnings results on Tuesday, May 5th. The company reported $0.44 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.37 by $0.07. Pediatrix Medical Group had a net margin of 9.02% and a return on equity of 19.94%. The company had revenue of $476.20 million for the quarter, compared to analysts’ expectations of $465.83 million. During the same quarter in the previous year, the company earned $0.33 earnings per share. Pediatrix Medical Group’s quarterly revenue was up 3.9% on a year-over-year basis. On average, sell-side analysts expect that Pediatrix Medical Group, Inc. will post 2.09 earnings per share for the current year.

Insiders Place Their Bets

In other Pediatrix Medical Group news, Director Shirley A. Weis sold 36,028 shares of the company’s stock in a transaction dated Wednesday, May 13th. The shares were sold at an average price of $23.75, for a total value of $855,665.00. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website. Company insiders own 1.80% of the company’s stock.

Pediatrix Medical Group Profile

Pediatrix Medical Group, Inc (NYSE:MD) is a national physician-led medical group specializing in high-acuity newborn, maternal-fetal and pediatric subspecialty care. Headquartered in Sunrise, Florida, the company delivers clinical services through hospital-based physician staffing, advanced practitioner support and telemedicine programs. Its core specialties include neonatology, maternal-fetal medicine, pediatric cardiology, pediatric critical care, pediatric emergency medicine and anesthesiology.

Founded in 1979 and formerly known as MEDNAX, the company rebranded as Pediatrix Medical Group in 2022 to align its corporate identity with its primary clinical offerings.